RA0137

antibody from Oursmab

Targeting: CEACAM5 CD66e, CEA

Western blot

ELISA

Immunocytochemistry

Flow cytometry

Functional assay

Antibody data

Submit

Validation data

Product number: RA0137 - Provider product page
Provider: Oursmab
Product name: Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)
Antibody type: Monoclonal
Description: Cergutuzumab is an investigational bispecific monoclonal antibody (specifically, a T-cell engager) developed for the treatment of solid tumors. It is designed using a novel CEACAM5-targeting platform to redirect and activate the patient's own T cells specifically against cancer cells expressing a certain tumor-associated antigen. Clinical trials have explored its potential in carcinoembryonic antigen (CEA)-positive advanced or metastatic adenocarcinomas, such as colorectal and lung cancers.
Reactivity: Human
Isotype: IgG
Vial size: 100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration: Bottled at the concentration indicated on the vial.
Storage: Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

CEACAM5 protein structure - RA0137 shown in red.